Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Comparing 30-Day and Extended-Stability Formulations Licensed 503A pharmacies may offer both standard 30-day formulations and extended-stability options reaching 90 days
The fibrosis staging report is the single most commonly missing document make sure it's attached and easy to find
What amount of liquid gastric contents clearly increases aspiration risk is something that seems, from my reding of this literature, to be less clear
Individual pharmacokinetic differences may affect drug absorption and metabolism
UK patients should understand that: Available evidence is largely from Phase 2 studies with relatively short follow-up periods Long-term cardiovascular outcome data are not yet available for either agent Phase 3 trials are ongoing, and results will inform future regulatory submissions to the MHRA UK patients interested in accessing these treatments through clinical trials may wish to consult the NIHR 'Be Part of Research' portal (bepartofresearch.nihr.ac.uk) or ClinicalTrials.gov for current recruitment opportunities
